{"id":{"repo_id":"marshall","oai_identifier":"oai:mds.marshall.edu:etd-2550"},"canonical_url":"https://search.ndltd.org/etd/marshall/oai:mds.marshall.edu:etd-2550","repository":{"repo_id":"marshall","name":"Marshall University","base_url":"https://mds.marshall.edu/do/oai/"},"display":{"title":"A Systems Approach to Dissecting the Role of the Mucosal Microbiome in Disease","abstract":"The microbial community harbored by the mammalian gastrointestinal tract, collectively called the gut microbiota, plays a critical role in host health, metabolism, and immunity. Quantifiable changes in the gut microbiota have been implicated in a myriad of pathologies, including autoimmune, metabolic, and neurodegenerative diseases. Because of the gut microbiota’s plasticity, manipulating this community for therapeutic benefit presents as a novel strategy to combat modern diseases. Yet, only a fraction of the total microbial diversity that exists within the gut has been successfully cultured in a laboratory, leaving the clinical implications and functional attributes of many gut microbes undetermined. To address this issue, studies in this dissertation focused on bioinformatically investigating (i) the role of dietary and genetic factors on the gut microbiota in metabolic syndrome and (ii) the anatomic niche and immunomodulating antigens of the culture-resistant commensal, Segmented Filamentous Bacteria (SFB). Comprehensive characterization of the cecal microbial community in normal and metabolic syndrome-susceptible mice revealed that dietary factors overshadow the effects of host genetics and are determinist of the microbial patterns that emerge in metabolically healthy or diseased hosts. Moreover, we identified a microbial community proximal to the Peyer’s Patches that was phylogenetically distinct from the cecum. Through a multi-omics approach, we show that independent of mouse genetics, vendor, age, or gender, SFB are highly abundant in the Peyer’s Patches mucosa. Our in silico antigen prediction analyses identified thirty-five potential antigens within the reference proteome of SFB. Shotgun proteomics of the murine ileal mucosa confirmed the in situ presence of several potential antigens expressed by SFB, of which included multiple flagellar proteins. To experimentally valid bioinformatically-inferred antigen targets, we developed a collection of broad-host bacterial vectors to enable microbial products of interest to be precisely expressed in vitro, ex vivo, and in vivo. Collectively, our studies reveal important findings about the mechanisms by which (i) exogenous factors modulate the gut microbiota and (ii) an endogenous microbe modulates the host immune system and provides a novel molecular platform by which microbial products of interest can be causally investigated in polymicrobial communities.","abstract_html":"The microbial community harbored by the mammalian gastrointestinal tract, collectively called the gut microbiota, plays a critical role in host health, metabolism, and immunity. Quantifiable changes in the gut microbiota have been implicated in a myriad of pathologies, including autoimmune, metabolic, and neurodegenerative diseases. Because of the gut microbiota’s plasticity, manipulating this community for therapeutic benefit presents as a novel strategy to combat modern diseases. Yet, only a fraction of the total microbial diversity that exists within the gut has been successfully cultured in a laboratory, leaving the clinical implications and functional attributes of many gut microbes undetermined. To address this issue, studies in this dissertation focused on bioinformatically investigating (i) the role of dietary and genetic factors on the gut microbiota in metabolic syndrome and (ii) the anatomic niche and immunomodulating antigens of the culture-resistant commensal, Segmented Filamentous Bacteria (SFB). Comprehensive characterization of the cecal microbial community in normal and metabolic syndrome-susceptible mice revealed that dietary factors overshadow the effects of host genetics and are determinist of the microbial patterns that emerge in metabolically healthy or diseased hosts. Moreover, we identified a microbial community proximal to the Peyer’s Patches that was phylogenetically distinct from the cecum. Through a multi-omics approach, we show that independent of mouse genetics, vendor, age, or gender, SFB are highly abundant in the Peyer’s Patches mucosa. Our in silico antigen prediction analyses identified thirty-five potential antigens within the reference proteome of SFB. Shotgun proteomics of the murine ileal mucosa confirmed the in situ presence of several potential antigens expressed by SFB, of which included multiple flagellar proteins. To experimentally valid bioinformatically-inferred antigen targets, we developed a collection of broad-host bacterial vectors to enable microbial products of interest to be precisely expressed in vitro, ex vivo, and in vivo. Collectively, our studies reveal important findings about the mechanisms by which (i) exogenous factors modulate the gut microbiota and (ii) an endogenous microbe modulates the host immune system and provides a novel molecular platform by which microbial products of interest can be causally investigated in polymicrobial communities.","abstract_has_math":false,"creators":["Blalock, Lexie Christine"],"institution":null,"degree_name":"Biomedical Sciences","degree_level":"Dissertation","degree_discipline":"Joan C. Edwards School of Medicine","degree_department":null,"school":null,"contributors":["Dr. Hongwei Yu, Committee Chairperson","Dr. James Denvir","Dr. Joseph Horzempa"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-21T19:57:42Z","subjects":["Medical Microbiology","Medical Sciences","Medicine and Health Sciences","Bacterial-mediated immune induction","microbiome","microbiome manipulation","Peyer's Patches","Segmented Filamentous Bacteria"],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://mds.marshall.edu/etd/1545","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://mds.marshall.edu/etd/1545","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://mds.marshall.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Amds.marshall.edu%3Aetd-2550","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Hongwei Yu, Committee Chairperson","Dr. James Denvir","Dr. Joseph Horzempa"]},{"key":"dc:creator","label":"Author","values":["Blalock, Lexie Christine"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2022-10-05T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2022-01-01T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Joan C. Edwards School of Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Biomedical Sciences"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Medical Microbiology","Medical Sciences","Medicine and Health Sciences","Bacterial-mediated immune induction","microbiome","microbiome manipulation","Peyer's Patches","Segmented Filamentous Bacteria"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://mds.marshall.edu/etd/1545"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The microbial community harbored by the mammalian gastrointestinal tract, collectively called the gut microbiota, plays a critical role in host health, metabolism, and immunity. Quantifiable changes in the gut microbiota have been implicated in a myriad of pathologies, including autoimmune, metabolic, and neurodegenerative diseases. Because of the gut microbiota’s plasticity, manipulating this community for therapeutic benefit presents as a novel strategy to combat modern diseases. Yet, only a fraction of the total microbial diversity that exists within the gut has been successfully cultured in a laboratory, leaving the clinical implications and functional attributes of many gut microbes undetermined. To address this issue, studies in this dissertation focused on bioinformatically investigating (i) the role of dietary and genetic factors on the gut microbiota in metabolic syndrome and (ii) the anatomic niche and immunomodulating antigens of the culture-resistant commensal, Segmented Filamentous Bacteria (SFB). Comprehensive characterization of the cecal microbial community in normal and metabolic syndrome-susceptible mice revealed that dietary factors overshadow the effects of host genetics and are determinist of the microbial patterns that emerge in metabolically healthy or diseased hosts. Moreover, we identified a microbial community proximal to the Peyer’s Patches that was phylogenetically distinct from the cecum. Through a multi-omics approach, we show that independent of mouse genetics, vendor, age, or gender, SFB are highly abundant in the Peyer’s Patches mucosa. Our in silico antigen prediction analyses identified thirty-five potential antigens within the reference proteome of SFB. Shotgun proteomics of the murine ileal mucosa confirmed the in situ presence of several potential antigens expressed by SFB, of which included multiple flagellar proteins. To experimentally valid bioinformatically-inferred antigen targets, we developed a collection of broad-host bacterial vectors to enable microbial products of interest to be precisely expressed in vitro, ex vivo, and in vivo. Collectively, our studies reveal important findings about the mechanisms by which (i) exogenous factors modulate the gut microbiota and (ii) an endogenous microbe modulates the host immune system and provides a novel molecular platform by which microbial products of interest can be causally investigated in polymicrobial communities."]},{"key":"dc:title","label":"Title","values":["A Systems Approach to Dissecting the Role of the Mucosal Microbiome in Disease"]}]}],"canonical_facts":{"dc:contributor":["Dr. Hongwei Yu, Committee Chairperson","Dr. James Denvir","Dr. Joseph Horzempa"],"dc:creator":["Blalock, Lexie Christine"],"dc:date.available":["2022-10-05T07:00:00Z"],"dc:date.created":["2022-01-01T08:00:00Z"],"dc:description.abstract":["The microbial community harbored by the mammalian gastrointestinal tract, collectively called the gut microbiota, plays a critical role in host health, metabolism, and immunity. Quantifiable changes in the gut microbiota have been implicated in a myriad of pathologies, including autoimmune, metabolic, and neurodegenerative diseases. Because of the gut microbiota’s plasticity, manipulating this community for therapeutic benefit presents as a novel strategy to combat modern diseases. Yet, only a fraction of the total microbial diversity that exists within the gut has been successfully cultured in a laboratory, leaving the clinical implications and functional attributes of many gut microbes undetermined. To address this issue, studies in this dissertation focused on bioinformatically investigating (i) the role of dietary and genetic factors on the gut microbiota in metabolic syndrome and (ii) the anatomic niche and immunomodulating antigens of the culture-resistant commensal, Segmented Filamentous Bacteria (SFB). Comprehensive characterization of the cecal microbial community in normal and metabolic syndrome-susceptible mice revealed that dietary factors overshadow the effects of host genetics and are determinist of the microbial patterns that emerge in metabolically healthy or diseased hosts. Moreover, we identified a microbial community proximal to the Peyer’s Patches that was phylogenetically distinct from the cecum. Through a multi-omics approach, we show that independent of mouse genetics, vendor, age, or gender, SFB are highly abundant in the Peyer’s Patches mucosa. Our in silico antigen prediction analyses identified thirty-five potential antigens within the reference proteome of SFB. Shotgun proteomics of the murine ileal mucosa confirmed the in situ presence of several potential antigens expressed by SFB, of which included multiple flagellar proteins. To experimentally valid bioinformatically-inferred antigen targets, we developed a collection of broad-host bacterial vectors to enable microbial products of interest to be precisely expressed in vitro, ex vivo, and in vivo. Collectively, our studies reveal important findings about the mechanisms by which (i) exogenous factors modulate the gut microbiota and (ii) an endogenous microbe modulates the host immune system and provides a novel molecular platform by which microbial products of interest can be causally investigated in polymicrobial communities."],"dc:identifier":["https://mds.marshall.edu/etd/1545"],"dc:subject":["Medical Microbiology","Medical Sciences","Medicine and Health Sciences","Bacterial-mediated immune induction","microbiome","microbiome manipulation","Peyer's Patches","Segmented Filamentous Bacteria"],"dc:title":["A Systems Approach to Dissecting the Role of the Mucosal Microbiome in Disease"],"thesis:degree_discipline":["Joan C. Edwards School of Medicine"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Biomedical Sciences"]},"updated_at":"2026-11-21T19:57:42Z"}